Back
Vertex Pharmaceuticals Vs. Biogen Industry Stock Comparison
Buy
64
VRTX
Vertex Pharmaceuticals
Last Price:
310.42
Seasonality Move:
11.09%
Buy
57
BIIB
Biogen
Last Price:
266.48
Seasonality Move:
0.17%
Buy
64
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $304.75. The Score for VRTX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Biogen (BIIB)
is a Buy
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $265.17. The Score for BIIB is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $304.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIIB Stock Price Chart
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.1 | Buy |
| Relative Strength Index (14 RSI): | 59.61 | Buy |
| Chaikin Money Flow: | 912904 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (287.95 - 297.97) | Buy |
| Bollinger Bands (100): | (291.24 - 314) | Buy |
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.67 | Sell |
| Relative Strength Index (14 RSI): | 45.63 | Sell |
| Chaikin Money Flow: | 56077 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (261.74 - 272.06) | Sell |
| Bollinger Bands (100): | (270.71 - 294.55) | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 298.79 | Buy |
| 20-day SMA: | 292.94 | Buy |
| 50-day SMA: | 299.9 | Buy |
| 200-day SMA: | 294.53 | Buy |
| 8-day EMA: | 298.76 | Buy |
| 20-day EMA: | 296.11 | Buy |
| 50-day EMA: | 297.4 | Buy |
| 200-day EMA: | 289.35 | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 264.21 | Buy |
| 20-day SMA: | 265.31 | Sell |
| 50-day SMA: | 277.35 | Sell |
| 200-day SMA: | 251.77 | Buy |
| 8-day EMA: | 264.2 | Buy |
| 20-day EMA: | 266.66 | Sell |
| 50-day EMA: | 272.74 | Sell |
| 200-day EMA: | 261.37 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.74 per share, a decrease this year of $0.17 per share, and an increase next year of $1.34 per share.
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.60 per share, and an increase next year of $0.73 per share.
Vertex Pharmaceuticals Technical Analysis
| Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biogen Technical Analysis
| Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||